EUVIMEDEUVIMED entdecken
Crossref

Panax notoginseng Saponins Alleviate OSF by Inhibiting Ferroptosis Through GPX4 Activation

Xinyue Zhang, Yujie Sun, Chenxi Zhao, Hong Zou, Liang Hu, Lixiang Wen iD, Qun Tang iD

Journal of Oral Pathology & Medicine · 2026

DOI: 10.1111/jop.70069 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Oral Pathology & Medicine, 2026. Verfasst von Xinyue Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Hunan University of Chinese Medicine, Changsha, Hunan, China. Hauptthemen laut MEDLINE: Ferroptosis, Saponins, Panax notoginseng, Phospholipid Hydroperoxide Glutathione Peroxidase. Die Arbeit nennt 42 Literaturangaben. Gefördert von: The Innovation and Entrepreneurship Training Program for Undergraduates in Hunan Province of China, Natural Science Foundation of Hunan Province, Education Department of Hunan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Oral submucous fibrosis (OSF) is a chronic progressive disease characterized by fibrosis. Panax notoginseng saponins (PNS) are effective components of the traditional Chinese medicine Panax notoginseng and play an important role in the treatment of OSF. However, the underlying mechanism of action for this medicine remains unclear. The aim of this study was to explore the effects of ferroptosis in OSF. Subjects and Methods The mice were divided into six groups. Mouth openings were detected. The buccal tissues were harvested for histomorphological analysis, western blot, and RT‐qPCR. The cells were harvested for CCK8 detection, western blot, RT‐qPCR, TEM, immunofluorescence, fluorescent probe, and colorimetry.

Results

PNS improved mouth opening, alleviated tissue cell damage, and inhibited ferroptosis and fibrosis in OSF rat models. Our study found that ferroptosis is closely related to arecoline‐induced OSF and that PNS inhibits ferroptosis by upregulating glutathione peroxidase 4 (GPX4) to alleviate OSF.

Conclusions

The research established OSF in vivo and in vitro, respectively, and the changes in the expression of fibrosis and ferroptosis‐related markers in these models were studied to provide a theoretical and experimental basis for the clinical prevention and treatment of OSF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisSaponinsPanax notoginsengPhospholipid Hydroperoxide Glutathione PeroxidaseAnimalsMiceRatsMaleFibrosisMice, Inbred C57BLRats, Sprague-DawleyDisease Models, Animal

Stichwörter der Autor:innen

Panax notoginseng saponinsGPX4HaCaTarecolineferroptosisoral submucous fibrosis

Substanzen

SaponinsPhospholipid Hydroperoxide Glutathione Peroxidaseglutathione peroxidase 4, mouse

Autor:innen und Institutionen

  • Hunan University of Chinese Medicine, Changsha, Hunan, China.

ORCID-Profile: Lixiang Wen, Qun Tang

Förderung

  • The Innovation and Entrepreneurship Training Program for Undergraduates in Hunan Province of China
  • Natural Science Foundation of Hunan Province
  • Education Department of Hunan Province

Zitieren

APA

Zhang, X., Sun, Y., Zhao, C., Zou, H., Hu, L., Wen, L., & Tang, Q. (2026). Panax notoginseng Saponins Alleviate OSF by Inhibiting Ferroptosis Through GPX4 Activation. Journal of Oral Pathology & Medicine. https://doi.org/10.1111/jop.70069

Vancouver

Zhang X, Sun Y, Zhao C, Zou H, Hu L, Wen L, et al. Panax notoginseng Saponins Alleviate OSF by Inhibiting Ferroptosis Through GPX4 Activation. Journal of Oral Pathology & Medicine. 2026. doi:10.1111/jop.70069

BibTeX
@article{Zhang2026,
  author = {Zhang, Xinyue and Sun, Yujie and Zhao, Chenxi and Zou, Hong and Hu, Liang and Wen, Lixiang and Tang, Qun},
  title = {Panax notoginseng Saponins Alleviate OSF by Inhibiting Ferroptosis Through GPX4 Activation},
  journal = {Journal of Oral Pathology & Medicine},
  year = {2026},
  doi = {10.1111/jop.70069}
}
Kostenlos starten →